Last reviewed · How we verify
NCT03810586
Comparing PPG-based Blood Pressure Measurement to the Gold Standard Manometer
NA trial testing Non-invasive measurement of blood pressure in Hypertension in 28 participants. Completed in 25 June 2020.
25 April 2020
Quick facts
| Lead sponsor | Biobeat Technologies Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 28 |
| Start date | 15 April 2019 |
| Primary completion | 25 April 2020 |
| Estimated completion | 25 June 2020 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Non-invasive measurement of blood pressure
Conditions studied
- Hypertension — all drugs for Hypertension →
- Blood Pressure Disorders — all drugs for Blood Pressure Disorders →
Sponsor
Biobeat Technologies Ltd.
Who can join
Adults 18 to 65, any sex, with Hypertension or Blood Pressure Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Continuous blood pressure (BP) measurement is in use today with an ambulatory, sphygmomanometer-based, device. This device, also called BP Holter, gives essential data for the clinician, allowing better hypertension (HTN) diagnosis and treatment. Alongside, the device has some substantial limitations preventing its use as a longer term BP monitoring allowing better HTN control. A new method of continuous BP monitoring, based on photo plethysmography (PPG), has been invented to ease patients' use and increase their responsiveness. This study aims to check whether the new, PPG-based method, of BP measurement can be as good as the current, gold standard, sphygmomanometer-based device.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Twenty-Four-Hour Ambulatory Blood Pressure Measurement Using a Novel Noninvasive, Cuffless, Wireless Device.
Nachman D, Gilan A, Goldstein N, Constantini K, et al · · 2021 · cited 35× · PMID 34143867 · DOI 10.1093/ajh/hpab095
Verify or expand the search:
- PubMed search for NCT03810586
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Biobeat Technologies Ltd. trials
Trials by the same sponsor.
- NCT07240831 — Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring ( · NA · not yet recruiting
- NCT04955184 — Comparing Cardiac Output Measurements Using a Wearable, Wireless, Non-invasive PPG-Based Device to a Swan Ganz Catheter · completed
- NCT04680039 — Early Warning of Intradialytic Hypotension in Hemodialysis Patients · completed
- NCT04635371 — Monitoring Patients With Acute Cardiac Disease Using a Wireless, Wearable, Non-invasive Monitor · completed
- NCT04548024 — Relation of Non-invasively Measured Parameters to Clinical Outcomes in CHF Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03810586 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biobeat Technologies Ltd.
- Last refreshed: 9 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03810586.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing